Get the Stockscreener App
0.39
1.22%
0.0047
After Hours:
.40
0.01
+2.56%
Invivyd Inc stock is traded at $0.39, with a volume of 640.17K.
It is up +1.22% in the last 24 hours and down -15.51% over the past month.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
See More
Previous Close:
$0.3853
Open:
$0.3827
24h Volume:
640.17K
Relative Volume:
0.61
Market Cap:
$46.59M
Revenue:
-
Net Income/Loss:
$-225.14M
P/E Ratio:
-0.199
EPS:
-1.96
Net Cash Flow:
$-192.27M
1W Performance:
-6.77%
1M Performance:
-15.51%
6M Performance:
-67.23%
1Y Performance:
-92.11%
1-Day Range:
$0.3546
$0.398
1-Week Range:
$0.3546
$0.50
52-Week Range:
$0.3546
$5.195
Invivyd Inc Stock (IVVD) Company Profile
Name
Invivyd Inc
Sector
Industry
Phone
(781) 819-0080
Address
1601 TRAPELO ROAD, WALTHAM
Compare IVVD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
0.39 | 46.59M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-26-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-19-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-01-23 | Initiated | H.C. Wainwright | Buy |
Invivyd Inc Stock (IVVD) Latest News
Invivyd Inc (IVVD) Volatility Hits 11.66% – Here Is What You Should Do - Stocks Register
We Might See A Profit From Invivyd, Inc. (NASDAQ:IVVD) Soon - Yahoo Finance
Invivyd seeks FDA nod for COVID-19 treatment in immunocompromised - MSN
Invivyd’s (IVVD) Buy Rating Reaffirmed at D. Boral Capital - Defense World
Invivyd's (IVVD) Buy Rating Reiterated at D. Boral Capital - MarketBeat
Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA's Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mild-to-Moderate COVID-19 in Certain Immunocompromi - The Manila Times
Invivyd, Inc. (NASDAQ:IVVD) Shares Bought by Barclays PLC - Defense World
Invivyd, Inc. (NASDAQ:IVVD) Sees Large Increase in Short Interest - Defense World
Invivyd (NASDAQ:IVVD) vs. iTeos Therapeutics (NASDAQ:ITOS) Head-To-Head Comparison - Defense World
D. Boral Capital Reiterates Buy Rating for Invivyd (NASDAQ:IVVD) - Defense World
What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday? - Yahoo Finance
Invivyd (NASDAQ:IVVD) Receives "Buy" Rating from D. Boral Capital - MarketBeat
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC - The Manila Times
Invivyd's PEMGARDA Shows Powerful Defense Against Dominant COVID Variant XEC in Latest Data - StockTitan
Barclays PLC Raises Stake in Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Why Invivyd, Inc. (IVVD) Is Among the Best Penny Stocks to Invest In According to Media? - Yahoo Finance
12 Best Penny Stocks to Invest in According to the Media - Insider Monkey
State Street Corp Increases Position in Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Invivyd Inc (NASDAQ: IVVD): A Blank Check? - Stocks Register
Invivyd director Terrance McGuire sells stock worth $131,528 By Investing.com - Investing.com Nigeria
Insider Selling: Invivyd, Inc. (NASDAQ:IVVD) Director Sells 86,545 Shares of Stock - MarketBeat
Invivyd director Terrance McGuire sells stock worth $131,528 - Investing.com India
Invivyd faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria
Invivyd faces Nasdaq delisting over share price rule - Investing.com
Terrance Mcguire Sells 119,805 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat
Terrance Mcguire Sells 83,817 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat
Terrance Mcguire Sells 75,776 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat
Invivyd director Terrance McGuire sells $164,867 in stock By Investing.com - Investing.com Nigeria
Invivyd director Terrance McGuire sells $164,867 in stock - Investing.com India
Charles Schwab Investment Management Inc. Sells 289,312 Shares of Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Insider Selling: Invivyd, Inc. (NASDAQ:IVVD) Director Sells 74,764 Shares of Stock - MarketBeat
Invivyd director Terrance McGuire sells shares worth $147,795 By Investing.com - Investing.com South Africa
Invivyd director Terrance McGuire sells shares worth $147,795 - Investing.com
Invivyd, Inc. (NASDAQ:IVVD) Director Sells $30,718.73 in Stock - MarketBeat
Invivyd director Terrance McGuire sells $103,384 in stock - Investing.com
Invivyd director Terrance McGuire sells $103,384 in stock By Investing.com - Investing.com South Africa
Adagio Therapeutics Stock Hits 52-Week Low at $0.57 Amid Challenges - Investing.com
Fmr LLC Sells 1,046,775 Shares of Invivyd, Inc. (NASDAQ:IVVD) - Defense World
Fmr LLC Decreases Stock Holdings in Invivyd, Inc. (NASDAQ:IVVD) - MarketBeat
Invivyd announces board member resignation By Investing.com - Investing.com South Africa
Invivyd announces board member resignation - Investing.com
Analysts Provide An Important Insights On Invivyd Inc (IVVD) - Stocks Register
Invivyd's (IVVD) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
HC Wainwright Cuts Invivyd (NASDAQ:IVVD) Price Target to $10.00 - Defense World
FY2024 Earnings Forecast for Invivyd Issued By HC Wainwright - Defense World
Invivyd Inc Stock (IVVD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Invivyd Inc Stock (IVVD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MCGUIRE TERRANCE | Director |
Dec 27 '24 |
Sale |
0.52 |
83,744 |
43,647 |
3,256,776 |
| MCGUIRE TERRANCE | Director |
Dec 30 '24 |
Sale |
0.48 |
86,545 |
41,784 |
3,170,231 |
| MCGUIRE TERRANCE | Director |
Dec 20 '24 |
Sale |
0.42 |
119,805 |
50,725 |
3,568,274 |
| MCGUIRE TERRANCE | Director |
Dec 26 '24 |
Sale |
0.54 |
83,817 |
45,563 |
3,340,520 |
| MCGUIRE TERRANCE | Director |
Dec 24 '24 |
Sale |
0.51 |
68,161 |
34,503 |
3,424,337 |
| MCGUIRE TERRANCE | Director |
Dec 23 '24 |
Sale |
0.45 |
75,776 |
34,076 |
3,492,498 |
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):